Clinical guidelines for metabolic syndrome: diagnosis, treatment, and prevention of complications

Metabolic syndrome is a combination of several interrelated abnormalities: increased waist circumference, elevated blood pressure, elevated triglycerides, low high-density lipoprotein cholesterol, and elevated fasting glucose. A joint statement from the International Diabetes Federation, the American Heart Association, the National Heart, Lung, and Blood Institute, and other organizations in 2009 endorsed the approach that typically defines a diagnosis as the presence of three or more of the five features. [1]

The main purpose of the diagnosis is to demonstrate that the patient is simultaneously at increased risk for type 2 diabetes, myocardial infarction, stroke, fatty liver disease, chronic kidney disease, and other metabolic complications. This is not a "slight weight gain," but a clinical signal that the body is already at increased cardiovascular and metabolic risk. [2]

Modern clinical guidelines typically don't offer a one-size-fits-all "cure" for metabolic syndrome. Treatment is component-based: body weight and waist circumference are adjusted separately, as are blood pressure, lipid profile, prediabetes or type 2 diabetes, fatty liver disease, sleep, smoking, and physical activity. [3]

Therefore, the correct clinical approach begins not with the question "which drug to prescribe," but with an assessment of overall risk. The physician must determine whether the patient already has type 2 diabetes, atherosclerotic cardiovascular disease, chronic kidney disease, liver disease, obstructive sleep apnea, hypertension, high low-density lipoprotein cholesterol, or a family history of early cardiovascular events. [4]

Clinical recommendations for metabolic syndrome can be formulated as follows: confirm the diagnosis, look for existing complications, assess cardiovascular risk, initiate intensive lifestyle modification, prescribe medications for specific indications, and then monitor the patient regularly rather than sporadically. [5]

Component of metabolic syndrome	What does it mean for risk?	What does a doctor usually do?
Increased waist circumference	A sign of visceral obesity and insulin resistance	Assesses body weight, nutrition, physical activity and indications for obesity treatment
High blood pressure	Increases the risk of stroke, heart attack, and kidney disease	Confirms the diagnosis and selects non-drug or drug treatment
Elevated triglycerides	Often reflect insulin resistance and excess calories	Adjusts nutrition, weight, alcohol, glucose and lipid therapy
Low HDL cholesterol	Atherogenic metabolic profile marker	Focuses on reducing overall risk rather than on "raising" the indicator at any cost
Elevated fasting glucose	Risk of prediabetes and type 2 diabetes	Prescribes re-confirmation and preventative interventions
Combination of 3 or more signs	The risk is higher than with 1 isolated factor	Provides comprehensive and long-term patient care

Source for table: 2009 joint statement and Endocrine Society guideline for primary prevention in people at metabolic risk.[6] [7]

Diagnostics: what criteria and examinations are needed

The most practical diagnostic approach is to look for 5 characteristics: waist circumference above ethnically and clinically accepted thresholds, triglycerides 150 mg/dL or higher, low HDL cholesterol, blood pressure 130/85 mmHg or higher, and fasting glucose 100 mg/dL or higher. The diagnosis is usually confirmed when 3 or more criteria are present, but the physician should consider medications that may have already normalized blood pressure, lipids, or glucose. [8]

Waist circumference is just as important as body mass index (BMI), because metabolic syndrome is primarily associated with visceral fat, or the fat around the internal organs. Two people with the same BMI may have different risks if one carries predominantly subcutaneous fat, while the other carries mostly abdominal fat. [9]

A minimum laboratory battery typically includes fasting glucose, glycosylated hemoglobin, lipid profile, creatinine with estimated glomerular filtration rate, urine albumin or albumin-to-creatinine ratio, liver enzymes, and, if needed, an oral glucose tolerance test. The United States Preventive Services Task Force recommends screening for prediabetes and type 2 diabetes in adults aged 35–70 years who are overweight or obese, and referral to effective preventive interventions if prediabetes is present. [10]

Blood pressure also needs to be assessed accurately: it's best not to limit yourself to a single measurement in the office, but to confirm elevated values with repeated measurements, home monitoring, or 24-hour monitoring, if available. The European Society of Cardiology, in its 2024 guidelines, emphasizes the importance of diagnosing and managing high blood pressure as a risk factor for cardiovascular events. [11]

In metabolic syndrome, it's important not to forget about the liver. Metabolically associated steatotic liver disease is closely linked to obesity, type 2 diabetes, and other cardiometabolic factors, and current European guidelines for 2024 emphasize the need to identify the risk of fibrosis in patients with such disorders. [12]

What to check	For what	How often to review
Waist circumference and body mass index	Assess abdominal obesity and weight dynamics	At each scheduled visit or at least once every 3-6 months during treatment
Blood pressure	To identify hypertension and assess control	At each visit, at home - according to the doctor's plan
Fasting glucose and glycosylated hemoglobin	Find prediabetes or type 2 diabetes	Usually 1-2 times a year, more often in case of violations
Lipid profile	Assess triglycerides, low-density lipoprotein cholesterol, and overall risk	Usually once a year or after a change in therapy
Creatinine and albumin in urine	Check your risk of chronic kidney disease	Usually once a year if there is an increased risk
Liver function tests and fibrosis risk assessment	Find metabolically associated liver disease	At risk, especially in obesity and diabetes

Source for table: United States Preventive Services Task Force, European Society of Cardiology and EASL, EASD, EASO. [13] [14] [15]

Nutrition: A basic recommendation without which medications work less effectively

Nutrition for metabolic syndrome shouldn't be limited to a short-term "2-week diet." The goal is to create a sustainable diet that helps reduce visceral fat, blood pressure, triglycerides, glucose, and overall cardiovascular risk. The American Heart Association's dietary guidelines emphasize the need to balance calorie intake with energy expenditure, eat more vegetables and fruits, and choose whole grains, healthy protein sources, and minimally processed foods. [16]

The most practical guideline is not a strict ban on all carbohydrates, but rather on the quality of carbohydrates. Vegetables, legumes, whole grains, berries, fruits in moderation, and foods high in dietary fiber are preferred; sugary drinks, baked goods, white bread, desserts, ultra-processed foods, and constant snacking are less desirable. [17]

Protein is essential for maintaining muscle mass while losing weight. Typically, preference is given to fish, seafood, legumes, low-fat dairy products, eggs, poultry, nuts, and seeds, while red and processed meats are limited. This approach aligns with cardiovascular dietary recommendations, which emphasize plant-based protein sources, fish, and minimally processed foods. [18]

Salt, alcohol, and total calories are particularly important for blood pressure. The American Heart Association recommends choosing and preparing foods with little salt, limiting alcohol consumption, and not starting alcohol for those who don't drink it. [19]

In practice, what's more beneficial for the patient is not a "perfect diet" that's impossible to follow, but a 3-6 month plan: reduce sugary drinks to 0, add protein to every main meal, increase vegetables, replace some refined carbohydrates with whole grains, limit late-night snacks, and track waist circumference. [20]

The purpose of nutrition	What to choose more often	What to limit
Reduction of visceral fat	Vegetables, legumes, whole grains, protein products	Sweet drinks, frequent snacks, large portions
Lowering triglycerides	Fish, vegetables, fiber, reducing alcohol	Sugar, excess fructose, alcohol, baked goods
Pressure control	Low-salt foods, vegetables, fruits, legumes	Salty snacks, sausages, fast food
Glucose control	Whole foods, fiber, regular meals	Sweets, juices, refined carbohydrates
Muscle support	Protein in every main meal	Very low protein diets
Long-term commitment	A diet that is actually possible to follow	Extreme schemes without medical supervision

Source for table: American Heart Association dietary guidance and Endocrine Society guideline. [21] [22]

Physical activity, sleep and weight loss

Physical activity is essential because it reduces insulin resistance, helps reduce waist circumference, and improves blood pressure, lipid profile, sleep, and mood. The World Health Organization recommends that adults get 150-300 minutes of moderate aerobic activity per week or 75-150 minutes of vigorous-intensity activity, as well as core strengthening exercises two or more days per week. [23]

You can start with walking, swimming, cycling, dancing, using an elliptical trainer, or any other activity that you can realistically manage. For patients with obesity, joint pain, shortness of breath, or hypertension, it's important not to jump-start the program, but rather gradually increase the duration and intensity to avoid injury and prevent quitting the program after two weeks. [24]

Strength training is especially important when losing weight because it helps preserve muscle. If a person loses only body weight without maintaining muscle, metabolism may decrease, weakness increases, and the risk of weight regain increases. [25]

Sleep and obstructive sleep apnea also need to be assessed. Metabolic syndrome is often associated with snoring, daytime sleepiness, high blood pressure, and obesity. If sleep apnea is suspected, the patient needs to be examined, as untreated apnea interferes with blood pressure, weight, and glucose control. [26]

Even a 5-10% weight loss can clinically improve blood pressure, glucose, triglycerides, and liver function in some patients. However, in severe obesity, more intensive therapy may be required: a structured weight loss program, drug treatment for obesity, or metabolic surgery, if indicated. [27]

Direction	Practical purpose	Comment
Aerobic activity	150-300 minutes of moderate activity per week	Can be divided into short sessions
Strength exercises	2 or more days a week	Helps maintain muscle mass
Weight loss	Minimum 5-10% as the first clinical goal	In severe obesity, goals may be higher.
Reducing sedentary time	Get up and move throughout the day	Especially important for office work
Dream	Identify sleep apnea and chronic sleep deprivation	Helps control blood pressure and weight
Long-term support	Monitoring and adjusting the plan	Needed to prevent weight gain

Source for table: World Health Organization, American Heart Association and American Diabetes Association. [28] [29] [30]

Drug therapy: it's not the "syndrome" that is treated, but its components

Medications for metabolic syndrome are selected based on specific diagnoses and risk levels. If hypertension is present, blood pressure is treated; if low-density lipoprotein cholesterol or cardiovascular risk is high, lipid-lowering therapy is prescribed; if prediabetes or type 2 diabetes mellitus are present, a strategy for preventing or treating hyperglycemia is chosen; if obesity is present, weight-loss medications are considered as indicated. [31]

In terms of blood pressure, current guidelines emphasize stricter monitoring in many patients, but with consideration of tolerability, age, frailty, and risk of side effects. In its 2024 guidelines, the European Society of Cardiology introduced a target systolic pressure range of 120–129 mmHg for most patients receiving therapy, if this level is well tolerated. [32]

Lipid therapy depends on more than just triglycerides and high-density lipoprotein cholesterol. The primary goal is to reduce atherogenic particles, primarily low-density lipoprotein cholesterol, according to individual risk; guidelines from the American College of Cardiology and the American Heart Association consider metabolic syndrome a factor that strengthens the case for statins in intermediate-risk patients. [33]

For prediabetes, the key is intensive lifestyle changes with weight control and physical activity. The United States Preventive Services Task Force recommends referring patients with prediabetes to effective preventive interventions, and the American Diabetes Association 2026 emphasizes the importance of preventing or delaying type 2 diabetes in obese and high-risk individuals. [34] [35]

In type 2 diabetes and obesity, medications that not only lower glucose but also help reduce body weight and cardiovascular risk are increasingly being used. The American Diabetes Association (ADA) 2026 guidelines for obesity drug therapy, cardiovascular, renal, and hepatic benefits of antidiabetic agents, and NICE (NICE) 2025 included semaglutide and tirzepatide in its guidelines for the drug treatment of obesity in certain patient groups. [36] [37]

Violation	What is treated?	Possible groups of interventions
Arterial hypertension	Blood pressure and overall cardiovascular risk	Salt reduction, weight, physical activity, antihypertensive drugs
High low-density lipoprotein cholesterol	Atherosclerotic risk	Statins, ezetimibe, proprotein convertase subtilisin-kexin type 9 inhibitors by risk
High triglycerides	Atherogenic profile and risk of pancreatitis at very high values	Weight loss, glucose control, alcohol abstinence, drug therapy according to level
Prediabetes	Prevention of type 2 diabetes	Intensive lifestyle program, sometimes metformin as indicated
Type 2 diabetes	Glucose, weight, heart, kidneys	Metformin, glucagon-like peptide 1 receptor agonists, sodium-glucose cotransporter 2 inhibitors, and other drugs
Obesity	Body weight, waist circumference, complications	Behavioral therapy, weight loss drugs, metabolic surgery as indicated

Source for table: American Diabetes Association 2026, European Society of Cardiology 2024, ACC/AHA cholesterol guideline and NICE obesity guidance. [38] [39] [40] [41]

Examination of complications: heart, kidneys, liver and blood vessels

Metabolic syndrome is dangerous not just because of its name, but because of its consequences. It is associated with an increased risk of atherosclerotic cardiovascular disease, type 2 diabetes, and target organ damage, so physicians should regularly assess not only weight and glucose levels, but also overall vascular risk. [42]

Age, gender, blood pressure, smoking, cholesterol, diabetes, chronic kidney disease, family history, and past events are important for the heart and blood vessels. If the risk is high, treatment should be more aggressive: lipid-lowering therapy, blood pressure control, smoking cessation, weight loss, and glucose control become not preventative "recommendations for the future" but a way to prevent heart attacks and strokes. [43]

Kidney function is assessed because hypertension, diabetes, obesity, and metabolic syndrome can damage the glomeruli and small vessels. Creatinine, with a glomerular filtration rate (GFR) calculation, and urine albumin are also useful, especially if high blood pressure, diabetes, or prediabetes are present. [44]

The liver is examined because metabolically associated steatotic liver disease often coexists with obesity, diabetes, and dyslipidemia. AASLD and European guidelines emphasize the need to identify patients at risk for progressive fibrosis rather than relying solely on the phrase "fatty liver" based on ultrasound imaging. [45] [46]

Additionally, the doctor may evaluate obstructive sleep apnea, gout, polycystic ovary syndrome, depression, chronic inflammation, chronic pain, and medications that contribute to weight gain. This approach makes treatment realistic: sometimes weight and glucose levels fail to improve not because of "poor exercise," but because of sleep, medications, pain, stress, or untreated underlying conditions. [47]

Organ or system	What to look for	Why is this important?
Heart and blood vessels	Atherosclerotic risk, past events, smoking	Determines the intensity of heart attack and stroke prevention
Kidneys	Decreased glomerular filtration rate, albumin in urine	Early detection of chronic kidney disease
Liver	Steatosis, risk of fibrosis, elevated enzymes	Metabolic liver disease can progress silently.
Dream	Snoring, daytime sleepiness, sleep apnea	Untreated sleep apnea worsens blood pressure and metabolism
Joints	Pain, limitation of activity, osteoarthritis	Pain interferes with physical activity and weight loss
Mental health	Depression, anxiety, eating disorders	Affects nutrition, sleep, medications and treatment adherence

Source for the table: American Diabetes Association 2026, AASLD guidance and EASL, EASD, EASO 2024. [48] [49] [50]

What should a practical observation plan look like?

During the initial visit, the physician confirms the criteria for metabolic syndrome, measures waist circumference, weight, body mass index, blood pressure, and reviews medications, diet, sleep, physical activity, smoking, alcohol, family history, and symptoms of complications. Laboratory tests are then ordered and the individual's cardiovascular risk is assessed. [51]

Measurable goals are typically set for the next three months: reducing body weight by at least 3-5% as a first step, increasing physical activity, reducing sugar and sugary beverage consumption, normalizing home blood pressure measurements, and initiating treatment for dyslipidemia or hyperglycemia as indicated. Such a short cycle is convenient because the patient sees the results and the doctor can quickly adjust the plan. [52]

After 3-6 months, assess changes in waist circumference, body weight, blood pressure, lipids, and glucose. If there is no improvement, the clinically correct conclusion is not to blame the patient, but to review the plan: clarify calorie intake, alcohol, sleep, medications, depression, sleep apnea, pain, access to physical activity, and indications for drug treatment for obesity. [53]

In the long term, what a patient needs is not a collection of disparate advice, but a system: a primary care physician or endocrinologist coordinates the plan, a cardiologist is involved if there is high risk or cardiovascular disease, a nutritionist helps with nutrition, a sleep specialist evaluates apnea, and a hepatologist is needed if there is a high risk of liver fibrosis. [54]

The main criterion for success is not just weight loss, but a reduction in overall risk. A good plan should result in a reduction in waist circumference, improvements in blood pressure, glucose, triglycerides, low-density lipoprotein cholesterol, sleep quality, physical endurance, and the risk of diabetes or cardiovascular events. [55]

Term	What to control	What to decide
First visit	Syndrome criteria, blood pressure, weight, waist, medications, risk factors	Confirm the diagnosis and create a starting plan
4-12 weeks	Weight, waist, blood pressure, tolerance to changes	Strengthen or simplify the program
3-6 months	Lipids, glucose, blood pressure, body weight	Decide on medications or their adjustments
6-12 months	Cardiovascular risk, kidneys, liver, sleep	Assess complications and long-term strategy
Annually	Kidneys, liver, lipids, glucose, drugs	Update treatment goals
If it worsens	Rapid weight gain, increased blood pressure, glucose, shortness of breath, chest pain	Exclude complications and reconsider therapy

Source for the table: ADA Standards of Care 2026, USPSTF and EASL, EASD, EASO 2024. [56] [57] [58]

Frequently asked questions

Is metabolic syndrome a diagnosis or simply a set of risk factors?
It is a clinical syndrome, a persistent combination of risk factors that often occur together and increase the likelihood of type 2 diabetes and cardiovascular disease. It is important not as a "label," but as a signal for comprehensive treatment of weight, blood pressure, lipids, and glucose. [59]

Is it possible to cure metabolic syndrome without medication?
For some people, yes, especially in the early stages, if they manage to reduce body weight, waist circumference, increase physical activity, and change their diet. But if blood pressure, lipids, or glucose remain high, medications are needed not "instead of lifestyle changes," but in addition to them, to reduce the risk of complications. [60]

What weight loss is considered beneficial?
Even a 5-10% weight loss can improve blood pressure, glucose, triglycerides, and liver function in many patients. In severe obesity or existing complications, the doctor may set higher goals and discuss drug therapy or metabolic surgery. [61]

Should everyone with metabolic syndrome take statins?
No, the decision depends on age, LDL cholesterol levels, diabetes, cardiovascular disease, and calculated risk. However, metabolic syndrome is considered a factor that strengthens the case for statins in people with intermediate risk. [62]

Why is the liver checked in metabolic syndrome?
Because obesity, insulin resistance, diabetes, and dyslipidemia are closely associated with metabolic-associated fatty liver disease. The danger lies not in the fatty liver itself, but in the risk of inflammation and fibrosis, which must be assessed separately. [63]

What's the minimum amount of physical activity needed?
For adults, the recommended daily intake is 150-300 minutes of moderate aerobic activity per week, or 75-150 minutes of vigorous activity, plus strength training two or more days per week. You can start small, but the goal should be regular and sustainable. [64]

When are weight loss medications needed?
They are considered when obesity or overweight with complications persists despite a diet and activity program, and the potential benefits outweigh the risks. In 2025, NICE specifically recommended the use of semaglutide and tirzepatide for weight management in certain patient groups. [65]

Can fasting glucose alone be used as a diagnostic tool?
No, because metabolic syndrome includes not only glucose but also waist circumference, blood pressure, triglycerides, and high-density lipoprotein cholesterol. Fasting glucose, glycosylated hemoglobin, or an oral glucose tolerance test can be used to diagnose diabetes or prediabetes. [66]

Key points from experts

Rita Rastogi Kalyani, MD, MPH, is the chief scientific and medical officer of the American Diabetes Association. Her key message in the context of the 2026 guidelines: modern care for diabetes, prediabetes, and obesity must be evidence-based, personalized, and consider not only glucose but also cardiovascular, renal, liver, and weight outcomes. [67]

Robert H. Eckel, MD, is an Emeritus Professor of Medicine at the University of Colorado Anschutz Medical Campus and a specialist in endocrinology, metabolism, diabetes, lipids, and cardiovascular risk. His clinical contributions highlight the importance of understanding metabolic syndrome as a continuum between obesity, insulin resistance, diabetes, lipid abnormalities, and cardiovascular disease, rather than as an isolated weight issue. [68]

Scott M. Grundy, MD, PhD, is a leading researcher in lipid metabolism, nutrition, and cardiovascular prevention and founding Director of the Center for Human Nutrition at the University of Texas Southwestern Medical Center. His approach remains clinically relevant: metabolic syndrome is a complex of multiple risk factors, and treatment should simultaneously reduce atherogenic dyslipidemia, blood pressure, glucose, abdominal obesity, and the overall risk of atherosclerotic events. [69]

Naveed Sattar, Professor of Metabolic Medicine at the University of Glasgow and Honorary Consultant in Metabolic Medicine at Glasgow Royal Infirmary, emphasizes the importance of prevention, beginning before the development of type 2 diabetes and heart attack, when patients already have abdominal obesity, elevated glucose, blood pressure, and dyslipidemia. [70]

Frank Tacke, professor and one of the lead authors of the 2024 European guidelines on metabolically associated fatty liver disease, is important for patients with metabolic syndrome because the liver should be considered a target organ for cardiometabolic risk, not a secondary finding on ultrasound. [71]

Result

Clinical guidelines for metabolic syndrome are built around a simple but rigorous logic: confirm 3 or more diagnostic criteria, assess cardiovascular risk, identify prediabetes or type 2 diabetes, check kidney and liver function, and then treat each component of the syndrome according to current guidelines. [72]

The mainstay of treatment remains reducing visceral fat, regular physical activity, a diet emphasizing whole foods, sleep management, smoking cessation, and alcohol reduction. However, in cases of persistent hypertension, dyslipidemia, prediabetes, type 2 diabetes, or complicated obesity, medications are needed as indicated, as the goal of treatment is not only to improve blood counts but to prevent heart attack, stroke, diabetes, kidney disease, and the progression of fatty liver disease. [73]